Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-000914
Filing Date
2023-01-05
Accepted
2023-01-05 15:41:59
Documents
1
Period of Report
2022-12-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12257
  Complete submission text file 0000899243-23-000914.txt   13620
Mailing Address 1000 MARINA BLVD STE 200 BRISBANE CA 94005
Business Address
BERGER FRANKLIN M (Reporting) CIK: 0001273885 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37410 | Film No.: 23511089

Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Issuer) CIK: 0001633932 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations